differences between semaglutide and tirzepatide vs. Ozempic: Comparing Diabetes Treatments & Weight Loss Benefits Tirzepatide and Semaglutide key differences,

Many people obtain prescriptions through telehealth platforms that partner with compounding pharmacies

Key results at 80 weeks: Participants on the 4 mg dose lost an average of 47.2 lbs (19.0%) Participants on the 12 mg dose lost an average of 70.3 lbs (28.3%) 45.3% of participants on the 12 mg dose achieved at least 30% weight loss a level historically associated with bariatric surgery outcomes The 4 mg dose showed a lower rate of discontinuation due to adverse events than even placebo In a study extension to 104 weeks, participants with a starting BMI of 35 or higher who received 12 mg lost up to an average of 85.0 lbs (30.3%)

Financial commitment Running both compounds simultaneously involves significant ongoing expense

This low dose allows doctors to observe how the body responds in the initial weeks